title: Use of red blood cell transfusion in palliative care services: is it still up to date or is cancer-related anaemia controlled better with erythropoietic agents?
authors.forename: S
authors.initials: S
authors.lastname: Tanneberger
authors.forename: G
authors.initials: G
authors.lastname: Melilli
authors.forename: E
authors.initials: E
authors.lastname: Strocchi
authors.forename: C
authors.initials: C
authors.lastname: Frenquelli
authors.forename: Q F
authors.initials: QF
authors.lastname: Pannuti
mesh_terms: D000740:Anemia / Q000628:therapy*; D017707:Erythrocyte Transfusion; D004921:Erythropoietin / Q000627:therapeutic use*; D006400:Hematocrit; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D010166:Palliative Care; D011379:Prognosis; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D012189:Retrospective Studies; D016019:Survival Analysis
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin